EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Management of Advanced Penile Cancer

Ramona Stelmach, Patrizia Giannatempo, Nicola Nicolai, Xavier Garcia Del Muro

Oncology Research and Treatment · 2025

DOI: 10.1159/000546246 ↗

At a glance

Übersichtsarbeit in Oncology Research and Treatment, 2025. Written by Ramona Stelmach and 3 co-authors. Institution: Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany, ramona.stelmach@med.uni-heid…. Major MEDLINE topics: Penile Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell. Cited 3 times so far (Crossref); 117 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background: Penile cancer is a rare, aggressive malignancy, with incidence varying geographically. The primary risk factor is human papillomavirus (HPV) infection. Squamous cell carcinoma represents the most common histological subtype, accounting for around 95% of cases. For advanced penile carcinoma, prognosis remains poor with a 5-year survival rate of 16% in stage IV disease. Treatment is largely centred on palliative systemic therapy. This review provides an overview of the evidence on palliative systemic treatment for advanced penile cancer, including chemotherapy, immunotherapy, and targeted therapy, as well as emerging treatment strategies. Summary: Cisplatin-based chemotherapy is the established first-line treatment for advanced penile cancer, but its efficacy is often limited and short-lived. Immune checkpoint inhibitors showed limited but promising efficacy in penile carcinoma, with some patients experiencing durable responses, particularly those with high tumour mutational burden, HPV positivity, or high PD-L1 expression, though further research is needed to identify predictive biomarkers for optimal patient selection. HPV vaccine-based therapies targeting HPV oncoproteins, adoptive T-cell therapies and agents like binatrafusp alfa are showing potential in HPV-associated cancers, though their role in penile cancer remains uncertain. Ongoing clinical trials are investigating potentially synergistic combination therapies, such as HPV vaccines with checkpoint inhibitors or immune therapies combined with chemotherapy or tyrosine kinase inhibitors. Key Messages: Cisplatin-based chemotherapy remains the first-line treatment for advanced penile cancer, while immunotherapy and targeted therapies show promise but require further investigation. Enrolling patients in clinical trials and conducting early tumour molecular sequencing, if possible, are crucial for improving outcomes and identifying effective treatment targets.

Subjects

MeSH terms (MEDLINE)

Penile NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellHumansMaleImmunotherapyPapillomavirus InfectionsImmune Checkpoint InhibitorsNeoplasm StagingPalliative CareCisplatinMolecular Targeted TherapyCombined Modality Therapy

Author keywords

ChemotherapyImmunotherapyPenile cancerSystemic treatmentTargeted therapy

Substances

Immune Checkpoint InhibitorsCisplatin

Authors and institutions

  • Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany, ramona.stelmach@med.uni-heidelberg.de.
  • Department of Genito-Urinary Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Urology Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Genitourinary Cancer and Sarcoma Unit, Institut Català d'Oncologia, Hospitalet, University of Barcelona, Barcelona, Spain.

Cite

APA

Stelmach, R., Giannatempo, P., Nicolai, N., & Garcia Del Muro, X. (2025). Management of Advanced Penile Cancer. Oncology Research and Treatment. https://doi.org/10.1159/000546246

Vancouver

Stelmach R, Giannatempo P, Nicolai N, Garcia Del Muro X. Management of Advanced Penile Cancer. Oncology Research and Treatment. 2025. doi:10.1159/000546246

BibTeX
@article{Stelmach2025,
  author = {Stelmach, Ramona and Giannatempo, Patrizia and Nicolai, Nicola and Garcia Del Muro, Xavier},
  title = {Management of Advanced Penile Cancer},
  journal = {Oncology Research and Treatment},
  year = {2025},
  doi = {10.1159/000546246}
}
Start for free →